IL6 and breast carcinoma: In our analysis of HER2, IL-6, and pSTAT3 levels in a panel of primary IBCs, we found substantial co-localization of HER2 and pSTAT3, consistent with pSTAT3 as a known key regulator of growth in HER2pos breast cancer cells [53,54].